Continuing Education Activity

Organophosphates (OP) are chemical substances produced by the process of esterification between phosphoric acid and alcohol. Organophosphates can undergo hydrolysis with the liberation of alcohol from the ester bond. These chemicals are the main components of herbicides, pesticides, and insecticides. OPs are also the main components of nerve gas. Acute or chronic exposure to OPs can produce varying toxicity levels in humans, animals, plants, and insects. OPs also are widely used in the production of plastics and solvents. This activity reviews the evaluation and treatment of organophosphate exposure and highlights the role of the interprofessional team in evaluating and treating patients with this condition.

Objectives:

• Summarize the agents that commonly contain organophosphates.
• Describe the mechanisms of action of organophosphate toxicity.
• Review the adverse effects of organophosphates.
• Outline the importance of collaboration and coordination of the interprofessional team can enhance patient care in patients exposed to organophosphate toxicity and improve patient outcomes.

Introduction

Organophosphates (OP) are chemical substances produced by the process of esterification between phosphoric acid and alcohol. Organophosphates can undergo hydrolysis with the liberation of alcohol from the ester bond. These chemicals are the main components of herbicides, pesticides, and insecticides. OPs are also the main components of nerve gas. Acute or chronic exposure to organophosphates can produce varying toxicity levels in humans, animals, plants, and insects. Organophosphates also are widely used in the production of plastics and solvents.

From the clinical perspective, OPs are of interest because of the toxicity produced from exposure. Nerve gas and organophosphate pesticides (OPP) are particularly important from a clinical standpoint because of the cholinergic symptoms produced from exposure.[1][2]

Function

Nerve Gas

Pioneers in the study of nerve gas include two French organic chemists, Jean Louis Lassange and Phillipe de Clermont. In the early 1930s, the German scientist Willy Lange first described the toxidromes associated with exposure to nerve gas as a choking sensation and dimming of vision. These are the cholinergic effects of exposure of the nervous system to organophosphates. Gerhard Schrader conducted experiments to harvest the use of these substances as insecticides. The Nazis in pre-World War II Germany saw the potential use of this chemical for warfare and later produced the G series of nerve gas during World War II, specifically sarin, tabun, and soman. The British were able to synthesize the VX nerve gas, more powerful and more potent than the G series.

The postwar period witnessed the entry of the United States into the synthesis of organophosphates after some American companies gained access to the works of Gerhard Schrader. The organophosphates produced were used as insecticides, with parathion and malathion being the first organophosphates pesticides to be synthesized in the US.

Nerve gas has been used from World War I to the present day as a chemical warfare agent. It was used extensively in World War II and the Gulf War. The most recent use of nerve gas was in the current war in Syria in 2013.[3][4]

In peacetime, the most extensive use of nerve gas was in 1994 and 1995 when Sarin was used for terrorism in Japan.[4]

The effects of nerve gas on the body can be profound.[5] Nerve gas overstimulates the muscarinic and nicotinic receptors as a result of the accumulation of ACh. This can cause seizure, agitation, and at high doses, respiratory arrest that is centrally induced. Peripheral overstimulation of the muscarinic and nicotinic receptors can cause a cholinergic crisis manifested by excessive sweating, salivation, lacrimation, blurry vision from miosis, and respiratory discomfort from bronchospasm.[6]

Chronic exposure to nerve gas like sarin can lead to the following neuroendocrine manifestations[7][8][9]:

• Delayed neurotoxicity
• Chronic neurotoxicity
• Endocrine disruption

Pesticides

The most commonly used organophosphate pesticides are the following:

1. Parathion
2. Chlorpyrifos   
3. Diazinon
4. Dichlorvos 
5. Phosmet 
6. Fenitrothion
7. Tetrachlorvinphos
8. Azamethiphos
9. Azinphos-Methyl
10. Malathion
11. Methyl Parathion

Carbamates

Another class of insecticides is carbamates which are chemically similar to organophosphate pesticides. They are derivatives of carbamic acid and cause carbamylation of acetylcholine esterase (AChE) at the level of neuronal synapses. Their binding to AChE is reversible, and the duration of action is about 24 hours.

Nerve Gas

Common nerve gasses are classified into three groups:

G series (developed by the Germans during WWII)

• Sarin
• Soman
• Tabun

V series (developed by the British)

• VE
• VG
• VM
• VR
• VM
• VX

Novichok

“Newcomer" (developed in the former Soviet Union in the late 70s and early 80s)

Issues of Concern

Mechanism of Action

Loewi demonstrated in 1921 that acetylcholine (ACh) is a chemical that can transmit nerve impulses from one nerve to another via synapses. ACh is a neurotransmitter that is derived from acetyl coenzyme A (Acetyl COA). Acetyl COA is derived from glucose and choline by a reaction catalyzed by choline acetyltransferase (CAT). ACh is stored in the presynaptic membrane in packages called vesicles. Each package is released upon stimulation. Acetylcholine esterase (AChE) uses a hydrolytic process to break down the neurotransmitter ACh into choline and acetate, thereby terminating its effect on the muscarinic and nicotinic receptors.[8]

Organophosphates have the ability to irreversibly bind to AChE and prevent the breakdown of ACh. “Liberation” of ACh leads to overstimulation of both the muscarinic and nicotinic receptors.

Nicotinic and muscarinic receptors are widely distributed in the body.

Nicotinic Receptors

• Nicotinic receptors are of two types: Central and peripheral
• Central nicotinic receptors Nn or N2 are located in the central nervous system (CNS). They can also be found in the sympathetic, parasympathetic ganglia of the peripheral nervous system (PNS) and the adrenal medulla
• Peripheral nicotinic receptors Nm or NI are located at the level of the neuromuscular junctions

Muscarinic Receptors

• All five subtypes of muscarinic receptors (M1-M5) are present in the CNS.
• The postganglionic peripheral muscarinic receptors provide parasympathetic innervation to the heart, exocrine glands, and the smooth muscles of the internal organs. Innervation of the sweat gland is via the sympathetic postganglionic fibers.[10][11]

Stimulations of each of the specific receptors will cause the following clinical signs and symptoms[12]:

Nicotinic Receptors

• N1 Neuromuscular junction - Fasciculation and muscular weakness
• N2 Autonomous nervous system - Hypertension and tachycardia

Muscarinic Receptors

• M2 Heart - Hypotension bradycardia
• M2, M3 Eyes - Miosis
• M2, M3 Gastrointestinal system - Abdominal cramps, drooling, salivation
• M2, M3 Respiratory system - Bronchospasm, bronchorrhea, rhinorrhea
• M2, M3 Smooth muscle of internal organ - Abdominal cramps, urinary urgency
• M1, M2, M3, M4, M5 Central Nervous System - Seizure, anxiety, agitation

Organophosphates manifest their clinical presentation mainly on the respiratory, gastrointestinal, cardiovascular, and central nervous system

Exposure to Organophosphates

Data on exposure to nerve gas and organophosphate pesticides are very limited. Most of the exposure to organophosphate pesticides is in rural areas where extensive use of herbicides, pesticides, and insecticides are common. Exposure might be accidental or intentional.

Exposure can be via food products such as wheat, flour, and cooking oil. Ant and roach spray might also be a potential source of exposure. Routes of exposure include the following:

• Inhalation
• Direct contact
• Ingestion

Worldwide, approximately 3 million people are exposed to organophosphates, with about 300,000 mortalities. In the United States, about 8,000 are exposed to organophosphates, with very few deaths. Since 2013, there are stricter government regulations for the sale of OPs.

By the Geneva Convention of 1925, the sale of nerve gas is considered a war crime. The most recent reported cases of extensive use of nerve gas are in the ongoing conflict in Syria.

Adverse Effects

Adverse effects from exposure to organophosphate pesticides can be classified based on the length of exposure.

• Acute - Occurs within minutes to 24 hours
• Subacute - Occurs between 24 hours and 2 weeks
• Chronic - Exposure beyond weeks to years

The main effect of acute exposure to organophosphates is poisoning. Organophosphate pesticides can be absorbed via the skin and integumentary system, respiratory system via inhalation, or direct ingestion. The most rapid clinical manifestation of organophosphate pesticides is seen via inhalation. Chronic exposure to OP can cause the same effects as seen in acute exposure. However, with chronic exposure, memory, speech loss, lack of coordination, and impaired judgment are also impaired. Chronic exposure to OP can also cause flu-like symptoms like nausea, vomiting, malaise, and weakness. Peripheral polyneuropathy has been linked to chronic exposure.  Exposure to some OPs has been associated with the possible development of cancer. Based on a report by the International Agency for Research on Cancer, malathion, diazinon, tetrachlorvinphos, and parathion are classified as possible carcinogens. The hallmark of exposure to either organophosphate pesticides or nerve gas is the ability of these substances to inhibit the action of AChE, the enzyme responsible for the breakdown of ACh. Organophosphate pesticides bind irreversibly to AChE in the plasma, red blood cells, and at the level of the synapses in both the PNS and the CNS. The buildup of ACh leads to the overstimulation of both the nicotinic receptors and the muscarinic receptors.[13][14]

Complications

The complications from exposure to nerve gas or organophosphate pesticide are related to each system that is affected. Overstimulation of both the nicotinic and muscarinic receptors is responsible for the clinical manifestation of these complications.[15]

 Respiratory System

• Aspiration pneumonia from excessive salivation
• Progressive respiratory failure from respiratory muscle weakness, especially diaphragmatic muscle
• Severe bronchospasm
• Noncardiogenic pulmonary edema[14]

Cardiovascular System

• Arrhythmias, especially ventricular tachycardia
• Bradycardia
• Hypertension
• Hypotension
• Prolonged QTc[16][17]

Central Nervous System

• Psychosis
• Seizure
• Change in mental status
• Hallucination[18][19]

Gastrointestinal and Metabolic Systems 

• Electrolyte abnormalities from fluid and electrolyte losses from the gastrointestinal tract[20]
• Pancreatitis
• Hyperglycemia
• Low bicarbonate [5][21]  

Renal System

• Acute kidney injury[22]
• There are few case reports of acute kidney injury associated with exposure to organophosphate pesticides. Treatment is usually conservative management or hemodialysis.[23][22]

Clinical Significance

Organophosphates have potential benefits as pesticides, but their use comes with risks. They also have been used as nerve agents due to their toxicity. As a result of their significant health risks, practitioners should be familiar with the signs and symptoms of toxic exposure as well as the treatment.

Enhancing Healthcare Team Outcomes

Exposure to organophosphates can be life-threatening. To improve patients outcomes and enhance patient safety, early recognition of the toxidromes associated with organophosphate poisoning is important. Coordination and transfer of care from the Emergency Room to the Intensive Care Unit should be facilitated promptly. An interprofessional approach with the active participation of all the health care providers, including clinicians, specialists (particularly a toxicologist), mid-level practitioners, nurses, and pharmacists, is essential for a good clinical outcome. A good resource to use is the Poison Control Center, available nationwide in the USA at 1-800-222-1222.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Robb EL, Baker MB. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 1, 2022. Organophosphate Toxicity. [PubMed: 29261901]

2.

Adeyinka A, Kondamudi NP. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 13, 2023. Cholinergic Crisis. [PubMed: 29494040]

3.

John H, van der Schans MJ, Koller M, Spruit HET, Worek F, Thiermann H, Noort D. Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network. Forensic Toxicol. 2018;36(1):61-71. [PMC free article: PMC5754388] [PubMed: 29367863]

4.

Tokuda Y, Kikuchi M, Takahashi O, Stein GH. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack. Resuscitation. 2006 Feb;68(2):193-202. [PubMed: 16325985]

5.

Dressel TD, Goodale RL, Arneson MA, Borner JW. Pancreatitis as a complication of anticholinesterase insecticide intoxication. Ann Surg. 1979 Feb;189(2):199-204. [PMC free article: PMC1397024] [PubMed: 426552]

6.

Abou-Donia MB, Siracuse B, Gupta N, Sobel Sokol A. Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review. Crit Rev Toxicol. 2016 Nov;46(10):845-875. [PMC free article: PMC5764759] [PubMed: 27705071]

7.

Marrs TC. Organophosphate poisoning. Pharmacol Ther. 1993;58(1):51-66. [PubMed: 8415873]

8.

Rusyniak DE, Nañagas KA. Organophosphate poisoning. Semin Neurol. 2004 Jun;24(2):197-204. [PubMed: 15257517]

9.

Faiz MS, Mughal S, Memon AQ. Acute and late complications of organophosphate poisoning. J Coll Physicians Surg Pak. 2011 May;21(5):288-90. [PubMed: 21575537]

10.

Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K, Sideri A, Zouridakis M, Tzartos SJ. Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J. 2007 Aug;274(15):3799-845. [PubMed: 17651090]

11.

Sellin AK, Shad M, Tamminga C. Muscarinic agonists for the treatment of cognition in schizophrenia. CNS Spectr. 2008 Nov;13(11):985-96. [PubMed: 19037177]

12.

Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006 Jul;148(5):565-78. [PMC free article: PMC1751864] [PubMed: 16751797]

13.

Peter JV, Cherian AM. Organic insecticides. Anaesth Intensive Care. 2000 Feb;28(1):11-21. [PubMed: 10701030]

14.

Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry. 1974 Jul;37(7):841-7. [PMC free article: PMC494792] [PubMed: 4853328]

15.

Peter JV, Sudarsan TI, Moran JL. Clinical features of organophosphate poisoning: A review of different classification systems and approaches. Indian J Crit Care Med. 2014 Nov;18(11):735-45. [PMC free article: PMC4238091] [PubMed: 25425841]

16.

Karki P, Ansari JA, Bhandary S, Koirala S. Cardiac and electrocardiographical manifestations of acute organophosphate poisoning. Singapore Med J. 2004 Aug;45(8):385-9. [PubMed: 15284933]

17.

Paul UK, Bhattacharyya AK. ECG manifestations in acute organophosphorus poisoning. J Indian Med Assoc. 2012 Feb;110(2):98, 107-8. [PubMed: 23029843]

18.

Jamal GA. Neurological syndromes of organophosphorus compounds. Adverse Drug React Toxicol Rev. 1997 Aug;16(3):133-70. [PubMed: 9512762]

19.

Eyer P. Neuropsychopathological changes by organophosphorus compounds--a review. Hum Exp Toxicol. 1995 Nov;14(11):857-64. [PubMed: 8588945]

20.

Saadeh AM. Metabolic complications of organophosphate and carbamate poisoning. Trop Doct. 2001 Jul;31(3):149-52. [PubMed: 11444336]

21.

Hamaguchi M, Namera A, Tsuda N, Uejima T, Maruyama K, Kanai T, Sakata I. Severe acute pancreatitis caused by organophosphate poisoning. Chudoku Kenkyu. 2006 Oct;19(4):395-9. [PubMed: 17133981]

22.

Rubio CR, Felipe Fernández C, Manzanedo Bueno R, Del Pozo BA, García JM. Acute renal failure due to the inhalation of organophosphates: successful treatment with haemodialysis. Clin Kidney J. 2012 Dec;5(6):582-3. [PMC free article: PMC4400561] [PubMed: 26069807]

23.

Agostini M, Bianchin A. Acute renal failure from organophospate poisoning: a case of success with haemofiltration. Hum Exp Toxicol. 2003 Mar;22(3):165-7. [PubMed: 12723899]